Filing Flows › Arcadia Biosciences (RKDA) › Q1 2026 › vs Q4 2025
Arcadia Biosciences (RKDA) Q1 2026 vs Q4 2025 (quarter over quarter)
Arcadia Biosciences's revenue rose $199K (+22%) from $901K in Q4 2025 to $1.1M in Q1 2026.
Arcadia Biosciences, Q1 2026: revenue $1.1M (-8% year over year), operating margin -70.8%, net loss $4.4M, operating cash flow −$1.1M. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $1.1M | $901K | $199K | +22% |
| Net loss | $4.4M | $1.3M | $3.1M | +238% |
| Costs & expenses | $5.5M | $2.3M | $3.2M | +141% |
| Operating costs | $1.9M | $2.3M | −$397K | -17% |
| Interest & other, net | $3.6M | −$78K | $3.7M | — |
| Cost of revenue | $700K | $709K | −$9K | -1% |
| SG&A | $1.2M | $1.6M | −$388K | -25% |
| Operating cash sources | $4.4M | $1.3M | $3.1M | +238% |
| Depreciation | $8K | $2K | $6K | +300% |
| Share-based compensation | $15K | $17K | −$2K | -12% |
| Working capital & other | $3.3M | $456K | $2.8M | +616% |
| Cash used in operations | $1.1M | $822K | $277K | +34% |
| Net loss absorbed | $4.4M | $1.3M | $3.1M | +238% |
Questions
How much did Arcadia Biosciences's revenue grow quarter over quarter in Q1 2026?
Arcadia Biosciences's revenue rose $199K (+22%) from $901K in Q4 2025 to $1.1M in Q1 2026.